Travere Therapeutics Inc. (TVTX)
20.46
-0.64 (-3.03%)
At close: Jan 29, 2025, 3:59 PM
20.40
-0.32%
After-hours Jan 29, 2025, 04:07 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| PE Ratio | -5.99 | -4.81 | -10.31 | -7.65 | -4.11 | -8.91 | -13.68 | -14.62 | 5.52 | -2.76 | -2.94 | -0.4 | -10.79 | n/a | n/a | -7.88K |
| PS Ratio | 4.60 | 6.32 | 8.16 | 6.53 | 3.43 | 5.57 | 5.27 | 5.24 | 6.48 | 10.87 | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 3.32 | 31.29 | 6.15 | 6.13 | 2.72 | 2.87 | 2.79 | 2.28 | 2.16 | -8.23 | -5.42 | -3.6 | -2.54 | n/a | n/a | 143.87M |
| P/FCF Ratio | -2.07 | -6.24 | -47.69 | -7.97 | -8.15 | -20.48 | -123.66 | -51.8 | -85.36 | -6.15 | -4.29 | -3.12 | -3.27K | n/a | n/a | -7.88K |
| P/OCF Ratio | -2.38 | -7.2 | -125.55 | -30.31 | -10.33 | -36.65 | 110.34 | -438.83 | -1.17K | -6.69 | -5.65 | -4.48 | -3.27K | n/a | n/a | -7.88K |
| OCF/S Ratio | -1.93 | -0.88 | -0.07 | -0.22 | -0.33 | -0.15 | 0.05 | -0.01 | -0.01 | -1.63 | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 2.02 | 9.51 | 0.87 | 1.02 | 0.93 | 0.68 | 0.15 | 0.14 | 0.15 | -2.25 | n/a | -0.26 | -0.4 | -0.41 | n/a | 4.17K |
| Quick Ratio | 3.41 | 3.37 | 4.64 | 4.35 | 4.43 | 4.68 | 3.74 | 3.96 | 3.49 | 0.34 | 0.21 | 0.01 | 0.06 | 0.06 | n/a | 0.14 |
| Current Ratio | 3.47 | 3.42 | 4.70 | 4.43 | 4.50 | 4.74 | 3.80 | 3.99 | 3.52 | 0.35 | 0.21 | 0.01 | 0.06 | 0.06 | n/a | 0.14 |
| Asset Turnover | 0.18 | 0.32 | 0.29 | 0.33 | 0.29 | 0.23 | 0.30 | 0.25 | 0.19 | 0.21 | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -33.24 | -22.31 | -6.93 | -3.96 | -5.3 | -8.16 | -45.28 | -1.69 | n/a | n/a | -1.23 | -285.46 | -6.41 | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.55 | -6.5 | -0.6 | -0.8 | -0.66 | -0.32 | -0.2 | -0.16 | 0.39 | 2.98 | 1.85 | 8.90 | 0.24 | n/a | n/a | -18.27K |
| Return on Assets (ROA) | -0.14 | -0.41 | -0.23 | -0.28 | -0.24 | -0.14 | -0.11 | -0.09 | 0.23 | -0.82 | -1.65 | -12.69 | -3.79 | n/a | n/a | -3.83 |
| Return on Capital (ROIC) | -0.62 | -0.47 | -0.21 | -0.15 | -0.2 | -0.13 | -0.12 | -0.13 | -0.12 | -2.86 | 1.63 | 8.87 | 0.20 | n/a | n/a | 0.63 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 92.12% | 96.42% | 97.02% | 96.91% | 97.01% | 96.63% | 97.67% | 96.59% | 97.81% | 97.98% | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -76.7% | -131.35% | -79.16% | -85.43% | -83.51% | -62.51% | -38.55% | -35.86% | 117.36% | -393.35% | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -258.96% | -131.2% | -78.98% | -95.19% | -83.52% | -62.02% | -37.67% | -43.1% | 105.58% | -402.07% | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -259.4% | -118.65% | -61.32% | -38.01% | -56.92% | -48.73% | -34.72% | -43.58% | -50.8% | -282.97% | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -221.9% | -101.33% | -17.12% | -81.98% | -42.08% | -27.19% | -4.26% | -10.12% | -7.59% | -176.62% | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -224.63% | -141.22% | -82.06% | -72.59% | -61.15% | -44.68% | -24.96% | -29.03% | 129.60% | -262.76% | n/a | n/a | n/a | n/a | n/a | n/a |